TRTME for Opioid Addiction

(TRTME Trial)

LB
BK
Overseen ByBen Kropp Kropp, MSLS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: T. John Winhusen, PhD
Must be taking: Methadone, Buprenorphine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary objective of this study is to evaluate the ability of TRTME to increase initiation of MOUD outpatient treatment and MOUD knowledge in hospitalized patients with OUD deemed to be good candidates for MOUD by the UCMC Addiction Consult Team (ACT). The secondary objective is to evaluate the ability of TRTME to decrease stigma and increase drug self-efficacy.

Who Is on the Research Team?

TJ

T. John Winhusen, PhD.

Principal Investigator

University of Cincinnati

Are You a Good Fit for This Trial?

This trial is for people who are hospitalized and have opioid use disorder (OUD). They must be considered good candidates to start medication treatment for OUD by the hospital's addiction team.

Inclusion Criteria

A good candidate for methadone or buprenorphine treatment according to a member of the UCMC Addiction Consult Team
I am 18 years old or older.

Exclusion Criteria

Have a current planned discharge to a nursing facility
Be currently in jail, prison, or any inpatient overnight facility as required by court of law or have pending legal action with high probability of incarceration or court-mandated inpatient treatment
I am unable to fully understand the study procedures.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Intervention

Participants receive either the TRTME intervention or control handouts

15 minutes
1 visit (in-person)

Follow-up

Participants are monitored for MOUD initiation and knowledge retention

4 weeks
1 follow-up call (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • TRTME

Trial Overview

The study is testing TRTME, a program designed to help patients with OUD begin outpatient medication treatment after leaving the hospital. It also aims to improve knowledge about these medications and reduce stigma.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: TRTMEExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

T. John Winhusen, PhD

Lead Sponsor

Trials
5
Recruited
750+